Rounds / Metajien Therapeutics
MT
Metajien Therapeutics raises ¥300M (Series B extension second close)
- Company
- Metajien Therapeutics
- Reported
- 28 Sept 2026 · that week's brief
- Stage
- Series B extension second close · 「シリーズBエクステンションラウンド セカンドクローズ」 ·
- Amount
- ¥300M1 · as announced: 「総額3億円」
- Breakdown
- Equity ¥300M
- Status
- Not yet registry-confirmed
- Notes
- Found via STARTUP LOG; checked against the company release. Instrument as stated: 第三者割当増資.
- Investors
- GLIN ImpactCapital · list incomplete (release ends with 等/ほか)
- Sector
- BiotechDeep tech
- Source
- Release (Release; no announcement found on the company's own site yet) · News coverage
1 ≈ ~$1.9M at the ECB reference rate on 2026-09-28 (¥1 = $0.00637). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →